Know a great AI tool or AI news source? Submit it to AiByts

Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing

Swiss tech-bio firm Atlas Bio today launched from stealth with a $10 million Seed round led by Creandum, alongside a previously unannounced pre-Seed round led by First Momentum Ventures and LEA Partne...

By Cate LawrenceTech.eu
Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing

Read the full story

Originally published by Tech.eu on Oct 27, 2026.

Read on Tech.eu(opens in a new tab)

Comments

Sign in to join the discussion.

No comments yet — be the first to share your thoughts.